Aethlon Medical
AEMD
12 hedge funds and large institutions have $437K invested in Aethlon Medical in 2020 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 4 increasing their positions, 0 reducing their positions, and 2 closing their positions.
616% more capital invested
Capital invested by funds: $61K → $437K (+$376K)
150% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 2
33% more funds holding
Funds holding: 9 → 12 (+3)
0% more ownership
Funds ownership: 0% → 0% (+0%)
Top Buyers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$230K |
| 2 |
Morgan Stanley
New York
|
+$146K |
| 3 |
AA
Ancora Advisors
Cleveland,
Ohio
|
+$64.3K |
| 4 |
SPC
Sigma Planning Corp
Ann Arbor,
Michigan
|
+$32.2K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$22K |
Top Sellers
| 1 |
Renaissance Technologies
New York
|
-$23K |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$4K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Vanguard Group
Malvern,
Pennsylvania
| $186K | +$230K | +136 | +800% |
|
|
2
Morgan Stanley
New York
| $106K | +$146K | +86 | +8,600% |
|
|
AA
3
Ancora Advisors
Cleveland,
Ohio
| $46K | +$64.3K | +38 | New |
|
|
SPC
4
Sigma Planning Corp
Ann Arbor,
Michigan
| $23K | +$32.2K | +19 | New |
|
|
CFN
5
Cordasco Financial Network
Naples,
Florida
| $21K | – | – | – |
|
|
6
Northern Trust
Chicago,
Illinois
| $16K | +$22K | +13 | New |
|
7
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $15K | +$22K | +13 | New |
|
8
UBS Group
Zurich,
Switzerland
| $7K | +$8.46K | +5 | +500% |
|
9
BlackRock
New York
| $6K | – | – | – |
|
10
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| $5K | +$5.08K | +3 | +300% |
|
11
Wells Fargo
San Francisco,
California
| $3K | – | – | – |
|
12
Osaic Holdings
Scottsdale,
Arizona
| $3K | +$3.39K | +2 | New |
|
|
GEA
13
Glen Eagle Advisors
Kingston,
New Jersey
| $47 | – | – | – |
|
|
14
Renaissance Technologies
New York
| – | -$23K | -30 | Closed |
|
|
15
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| – | -$4K | -6 | Closed |
|
AEMD Hedge Fund Activity: Q1 2020 in Review
12 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Aethlon Medical (AEMD) for Q1 2020, worth a combined $437K — up 616% from $61K a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new AEMD positions and 2 closed out — a net gain of 3 holders — while 4 added to existing stakes and 0 trimmed.
The largest buyer was Vanguard Group, adding an estimated $230K. The largest seller was Renaissance Technologies, exiting entirely with an estimated $23K sold.
- 12 institutional investors held Aethlon Medical (AEMD) as of Q1 2020, up from 9 in Q4 2019.
- Funds reported $437K of Aethlon Medical stock for Q1 2020, up 616% quarter-over-quarter.
- 5 funds opened new Aethlon Medical positions in Q1 2020 and 2 closed out, a net change of +3 holders.
- The largest Aethlon Medical buyer in Q1 2020 was Vanguard Group, an estimated $230K added.
- The largest Aethlon Medical seller in Q1 2020 was Renaissance Technologies, an estimated $23K sold.
Based on aggregated 13F filings for Q1 2020.